Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1993-5-19
pubmed:abstractText
Glanzmann's thrombasthenia (GT) is the result of the absence or of an altered and dysfunctional expression on the platelet membrane of the fibrinogen receptor (glycoprotein [GP] IIb/IIIa complex). Various molecular genetic mechanisms have been found to be responsible for this inherited disease. In a patient with a severe type of GT, we have found a splice variant in the GP IIIa gene that leads to premature chain termination. Immunoprecipitation experiments, using monoclonal antibodies specific for GP IIb/IIIa, showed that GP IIb/IIIa was not detectable on the platelet membrane. Amplification of reversely transcribed platelet GP IIIa mRNA by the polymerase chain reaction and subsequent sequence analysis showed a 86-bp deletion, which corresponds to exon i of the GP IIIa gene. This deletion results in a shift of the reading frame leading to eight altered amino acids followed by a premature termination codon. Analysis of the corresponding genomic DNA fragments showed three mutations in the exon i-intron i boundary region of the GP IIIa gene. One of these mutations is a G-->T transition that eliminates the GT splice donor site in the wild type. This base pair change creates a restriction site for the enzyme Mse I. Allele-specific restriction enzyme analysis (ASRA) with Mse I of amplified genomic DNA of the parents and the proposita showed that both parents (who are first cousins) are heterozygous, whereas the proposita is homozygous for the G-->T substitution.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2044-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8471765-Adult, pubmed-meshheading:8471765-Amino Acid Sequence, pubmed-meshheading:8471765-Antibodies, Monoclonal, pubmed-meshheading:8471765-Base Sequence, pubmed-meshheading:8471765-Blood Platelets, pubmed-meshheading:8471765-DNA, pubmed-meshheading:8471765-Deoxyribonucleases, Type II Site-Specific, pubmed-meshheading:8471765-Exons, pubmed-meshheading:8471765-Female, pubmed-meshheading:8471765-Gene Deletion, pubmed-meshheading:8471765-Homozygote, pubmed-meshheading:8471765-Humans, pubmed-meshheading:8471765-Immunosorbent Techniques, pubmed-meshheading:8471765-Molecular Sequence Data, pubmed-meshheading:8471765-Platelet Membrane Glycoproteins, pubmed-meshheading:8471765-Polymerase Chain Reaction, pubmed-meshheading:8471765-RNA, Messenger, pubmed-meshheading:8471765-RNA Splicing, pubmed-meshheading:8471765-Thrombasthenia
pubmed:year
1993
pubmed:articleTitle
Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA.
pubmed:affiliation
Department of Immunological Haematology, Central Laboratory of the Netherlands, Red Cross Blood Transfusion Service, Amsterdam.
pubmed:publicationType
Journal Article, Case Reports